The National Advisory Committee on Immunization (NACI) and the Comité sur l’immunisation du Québec (CIQ) has updated their COVID-19 booster recommendations for patients at high-risk of COVID-19. Although many patients feel that their risk of severe COVID-19 is minimal, there are a large portion of Canadians who are at significantly elevated risk. This webinar will address the key issues that you will need to know to mitigate severe COVID-19 risk in these vulnerable populations.
Note: This webinar was recorded on April 27th, 2023.
This program has received funding from Moderna Biopharm Canada Inc.